Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-10-15
2022-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The general objective of this study is to observe possible oral language and attention disorders in children with epilepsy, by age and etiology of epilepsy.
The objective of this work is to study therapeutic apheresis (including plasma exchange and immunoadsorption) among french neuropediatric tertiary centers and to prove that this treatment modality is effective and well tolerated in pediatric neurology diseases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Specific Language Impairment (SLI) in Children May Caused by Epileptic Brain Activity
NCT04141332
EEG Changes in Pediatrics With Language Dysfunction Evaluation of Sleep EEG Changes in Paediatric Patients With Language Dysfunction: A Follow up Study. EEG Changes in Pediatrics With Language Dysfunction
NCT05487521
Developmental Language Difficulties: Behavioural and Electrophysiological Studies
NCT02872870
Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
NCT04926311
Language and Motor Skills of Preterm Infants in Pre-school Age: Diagnosis and Early Intervention
NCT01426659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 3 years old and at most 15 years old
* Be French speaker
* Be in a regular class
* Have a diagnosis of epilepsy
Exclusion Criteria
* Subjects diagnosed with austim spectrum disorder
* Subjects with a motor or visual handicap
* Subjects with psychiatric disorders
3 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxime colmard, résident
Role: PRINCIPAL_INVESTIGATOR
UH MONTPELLIER
Moritz-Gasser Sylvie
Role: STUDY_CHAIR
UH MONTPELLIER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uh Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL21_0638
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.